Is There Hope for Improving Drug Development Productivity?
I was recently reading yet another paper bemoaning the dropping productivity in drug development. The authors were discussing the most likely explanations for the decline, which were
- tighter regulation
- illusory decline (no actual decline)
- depletion of low-hanging fruit
- increasing risk aversion by the drug companies
- rising hurdles on safety
I mention this only because the paper was written in 1978 Continue reading “Improving Productivity”